NIDDK Central Repository - Plasma Concentrations of Per- and Polyfluoroalkyl Substances at Baseline and Associations with Glycemic Indicators and Diabetes Incidence among High-Risk Adults in the Diabetes Prevention Program Trial.

An official website of the United States government

NIDDK Central Repository

Publication Information

DOI

10.1289/EHP1612

PubMed ID

28974480

Public Release Type

Journal

Publication Year

2017

Affiliation

Division of Chronic Disease Research Across the Lifecourse, Department of Population Medicine, Harvard Medical School and Harvard Pilgrim HealthCare Institute , Boston, Massachusetts, USA.

Authors

Calafat AM, Cardenas A, Gold DR, Hauser R, Hivert MF, Horton ES, Kleinman KP, Oken E, Webster TF, Ye X

Studies

DPP

Citation

Cardenas A, Gold DR, Hauser R, Kleinman KP, Hivert MF, Calafat AM, Ye X, Webster TF, Horton ES, Oken E. Plasma Concentrations of Per- and Polyfluoroalkyl Substances at Baseline and Associations with Glycemic Indicators and Diabetes Incidence among High-Risk Adults in the Diabetes Prevention Program Trial. Environ Health Perspect 2017 Oct 2;125(10):107001.

Abstract

Several per- and polyfluoroalkyl substances (PFAS) are ubiquitous anthropogenic pollutants almost universally detected in humans. Experimental evidence indicates that PFAS alter glucose metabolism and insulin secretion. However, epidemiological studies have yielded inconsistent results.